Ambrosia Biosciences announces a second closing of its Series A financing. This closing was led by Merck with additional participation from existing investors. This financing will further expand preclinical development operations in our facility in Boulder, CO. BOULDER, Colo., Dec. 10,…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
